Direct-acting antivirals used in HCV-related liver disease do not affect thyroid function and autoimmunity.
R RodiaP E MeloniC MasciaC BalestrieriV RuggieroG SerraM ContiM LoiF PesS OnaliA PerraR LitteraF VelluzziS MariottiL ChessaFrancesco BoiPublished in: Journal of endocrinological investigation (2022)
This study supports evidence that DAAs have a limited or missing influence on thyroid in patients with HCV-related diseases. Moreover, it provides preliminary evidence that subclinical non-autoimmune thyroid dysfunction may improve after HCV infection resolution obtained by DAAs.